advisorsecurities master

XNCRXencor, Inc.

CSNasdaq (XNAS)·USD

Identity

Security key
23948
Ticker
XNCR
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2013-12-03
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
XNCR

Detail

Enriched 2026-08-14 20:47

Market cap
$1,723,511,742.46
Shares outstanding (class)
74,353,397
Shares outstanding (weighted)
74,353,397
SIC
2834 PHARMACEUTICAL PREPARATIONS
Employees
260
Location
PASADENA, CA
Description

Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data